nodes	percent_of_prediction	percent_of_DWPC	metapath
Tocainide—ALB—Estropipate—osteoporosis	0.342	0.393	CbGbCtD
Tocainide—CYP1A2—Estropipate—osteoporosis	0.205	0.235	CbGbCtD
Tocainide—ALB—Estradiol—osteoporosis	0.142	0.163	CbGbCtD
Tocainide—CYP1A2—Conjugated Estrogens—osteoporosis	0.0968	0.111	CbGbCtD
Tocainide—CYP1A2—Estradiol—osteoporosis	0.085	0.0976	CbGbCtD
Tocainide—ALB—Platelet degranulation—PLEK—osteoporosis	0.000826	0.00641	CbGpPWpGaD
Tocainide—SCN7A—Developmental Biology—WNT1—osteoporosis	0.000823	0.00639	CbGpPWpGaD
Tocainide—SCN5A—Cardiac Progenitor Differentiation—IGF1—osteoporosis	0.000808	0.00627	CbGpPWpGaD
Tocainide—ALB—Binding and Uptake of Ligands by Scavenger Receptors—COL1A1—osteoporosis	0.000791	0.00613	CbGpPWpGaD
Tocainide—ALB—Response to elevated platelet cytosolic Ca2+—PLEK—osteoporosis	0.000787	0.0061	CbGpPWpGaD
Tocainide—CYP1A2—Estrogen Receptor Pathway—ESR1—osteoporosis	0.000758	0.00588	CbGpPWpGaD
Tocainide—SCN11A—Developmental Biology—WNT1—osteoporosis	0.000734	0.00569	CbGpPWpGaD
Tocainide—ALB—Platelet degranulation—TLN1—osteoporosis	0.000712	0.00552	CbGpPWpGaD
Tocainide—SCN9A—Developmental Biology—TLN1—osteoporosis	0.000706	0.00548	CbGpPWpGaD
Tocainide—SCN5A—Developmental Biology—CAP1—osteoporosis	0.000703	0.00545	CbGpPWpGaD
Tocainide—ALB—Platelet degranulation—VCL—osteoporosis	0.000703	0.00545	CbGpPWpGaD
Tocainide—SCN9A—Developmental Biology—ACTG1—osteoporosis	0.000697	0.0054	CbGpPWpGaD
Tocainide—ALB—Response to elevated platelet cytosolic Ca2+—TLN1—osteoporosis	0.000678	0.00526	CbGpPWpGaD
Tocainide—SCN3A—Developmental Biology—TLN1—osteoporosis	0.000676	0.00524	CbGpPWpGaD
Tocainide—SCN8A—Developmental Biology—WNT1—osteoporosis	0.000671	0.00521	CbGpPWpGaD
Tocainide—ALB—Response to elevated platelet cytosolic Ca2+—VCL—osteoporosis	0.000669	0.00519	CbGpPWpGaD
Tocainide—SCN3A—Developmental Biology—ACTG1—osteoporosis	0.000667	0.00517	CbGpPWpGaD
Tocainide—SCN5A—SIDS Susceptibility Pathways—ESR2—osteoporosis	0.000649	0.00503	CbGpPWpGaD
Tocainide—SCN2A—Developmental Biology—TLN1—osteoporosis	0.000649	0.00503	CbGpPWpGaD
Tocainide—SCN4A—Developmental Biology—TLN1—osteoporosis	0.000649	0.00503	CbGpPWpGaD
Tocainide—SCN2A—Developmental Biology—ACTG1—osteoporosis	0.00064	0.00497	CbGpPWpGaD
Tocainide—SCN4A—Developmental Biology—ACTG1—osteoporosis	0.00064	0.00497	CbGpPWpGaD
Tocainide—ALB—Platelet activation, signaling and aggregation—WDR1—osteoporosis	0.000638	0.00495	CbGpPWpGaD
Tocainide—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	0.000636	0.00493	CbGpPWpGaD
Tocainide—CYP1A2—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	0.000628	0.00487	CbGpPWpGaD
Tocainide—SCN10A—Developmental Biology—TLN1—osteoporosis	0.000626	0.00485	CbGpPWpGaD
Tocainide—SCN1A—Developmental Biology—TLN1—osteoporosis	0.000626	0.00485	CbGpPWpGaD
Tocainide—SCN10A—Developmental Biology—ACTG1—osteoporosis	0.000618	0.00479	CbGpPWpGaD
Tocainide—SCN1A—Developmental Biology—ACTG1—osteoporosis	0.000618	0.00479	CbGpPWpGaD
Tocainide—SCN5A—Axon guidance—TLN1—osteoporosis	0.000617	0.00478	CbGpPWpGaD
Tocainide—SCN5A—Axon guidance—ACTG1—osteoporosis	0.000608	0.00472	CbGpPWpGaD
Tocainide—SCN9A—Developmental Biology—WNT1—osteoporosis	0.000543	0.00421	CbGpPWpGaD
Tocainide—ALB—Platelet degranulation—FGA—osteoporosis	0.000532	0.00413	CbGpPWpGaD
Tocainide—SCN3A—Developmental Biology—WNT1—osteoporosis	0.000519	0.00403	CbGpPWpGaD
Tocainide—CYP1A2—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	0.000515	0.004	CbGpPWpGaD
Tocainide—ALB—Response to elevated platelet cytosolic Ca2+—FGA—osteoporosis	0.000507	0.00393	CbGpPWpGaD
Tocainide—ALB—Platelet activation, signaling and aggregation—CAP1—osteoporosis	0.000504	0.00391	CbGpPWpGaD
Tocainide—SCN2A—Developmental Biology—WNT1—osteoporosis	0.000499	0.00387	CbGpPWpGaD
Tocainide—SCN4A—Developmental Biology—WNT1—osteoporosis	0.000499	0.00387	CbGpPWpGaD
Tocainide—SCN5A—Cardiac Progenitor Differentiation—TGFB1—osteoporosis	0.000485	0.00376	CbGpPWpGaD
Tocainide—ALB—Platelet degranulation—FGB—osteoporosis	0.000484	0.00376	CbGpPWpGaD
Tocainide—SCN1A—Developmental Biology—WNT1—osteoporosis	0.000481	0.00373	CbGpPWpGaD
Tocainide—SCN10A—Developmental Biology—WNT1—osteoporosis	0.000481	0.00373	CbGpPWpGaD
Tocainide—SCN7A—Axon guidance—IL6R—osteoporosis	0.000469	0.00364	CbGpPWpGaD
Tocainide—ALB—Vitamin B12 Metabolism—SOD2—osteoporosis	0.000464	0.0036	CbGpPWpGaD
Tocainide—ALB—Response to elevated platelet cytosolic Ca2+—FGB—osteoporosis	0.000461	0.00358	CbGpPWpGaD
Tocainide—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	0.00046	0.00357	CbGpPWpGaD
Tocainide—SCN5A—Developmental Biology—TLN1—osteoporosis	0.00044	0.00341	CbGpPWpGaD
Tocainide—SCN5A—Developmental Biology—ACTG1—osteoporosis	0.000434	0.00337	CbGpPWpGaD
Tocainide—SCN11A—Axon guidance—IL6R—osteoporosis	0.000418	0.00324	CbGpPWpGaD
Tocainide—CYP1A2—Tryptophan metabolism—CYP19A1—osteoporosis	0.000413	0.0032	CbGpPWpGaD
Tocainide—ALB—Vitamin B12 Metabolism—MTHFR—osteoporosis	0.000409	0.00317	CbGpPWpGaD
Tocainide—ALB—Platelet activation, signaling and aggregation—MGLL—osteoporosis	0.000401	0.00311	CbGpPWpGaD
Tocainide—SCN7A—Developmental Biology—LEP—osteoporosis	0.000399	0.0031	CbGpPWpGaD
Tocainide—SCN8A—Axon guidance—IL6R—osteoporosis	0.000382	0.00296	CbGpPWpGaD
Tocainide—ALB—Folate Metabolism—SOD2—osteoporosis	0.000378	0.00293	CbGpPWpGaD
Tocainide—ALB—Platelet activation, signaling and aggregation—PLEK—osteoporosis	0.000367	0.00284	CbGpPWpGaD
Tocainide—ALB—Folate Metabolism—GPX1—osteoporosis	0.00036	0.00279	CbGpPWpGaD
Tocainide—SCN11A—Developmental Biology—LEP—osteoporosis	0.000356	0.00276	CbGpPWpGaD
Tocainide—SCN5A—SIDS Susceptibility Pathways—IL6R—osteoporosis	0.000346	0.00268	CbGpPWpGaD
Tocainide—SCN5A—Developmental Biology—WNT1—osteoporosis	0.000338	0.00262	CbGpPWpGaD
Tocainide—SCN7A—Developmental Biology—IL6R—osteoporosis	0.000335	0.0026	CbGpPWpGaD
Tocainide—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	0.000334	0.00259	CbGpPWpGaD
Tocainide—ALB—Folate Metabolism—MTHFR—osteoporosis	0.000333	0.00258	CbGpPWpGaD
Tocainide—CYP1A2—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	0.00033	0.00256	CbGpPWpGaD
Tocainide—ALB—Hemostasis—WDR1—osteoporosis	0.000329	0.00255	CbGpPWpGaD
Tocainide—SCN8A—Developmental Biology—LEP—osteoporosis	0.000326	0.00252	CbGpPWpGaD
Tocainide—ALB—Platelet activation, signaling and aggregation—TLN1—osteoporosis	0.000316	0.00245	CbGpPWpGaD
Tocainide—CYP1A2—Arachidonic acid metabolism—GPX1—osteoporosis	0.000315	0.00244	CbGpPWpGaD
Tocainide—ALB—Platelet activation, signaling and aggregation—VCL—osteoporosis	0.000312	0.00242	CbGpPWpGaD
Tocainide—SCN9A—Axon guidance—IL6R—osteoporosis	0.000309	0.0024	CbGpPWpGaD
Tocainide—ALB—Selenium Micronutrient Network—SOD2—osteoporosis	0.0003	0.00233	CbGpPWpGaD
Tocainide—SCN11A—Developmental Biology—IL6R—osteoporosis	0.000298	0.00231	CbGpPWpGaD
Tocainide—SCN3A—Axon guidance—IL6R—osteoporosis	0.000296	0.00229	CbGpPWpGaD
Tocainide—ALB—Selenium Micronutrient Network—GPX1—osteoporosis	0.000286	0.00222	CbGpPWpGaD
Tocainide—SCN2A—Axon guidance—IL6R—osteoporosis	0.000284	0.0022	CbGpPWpGaD
Tocainide—SCN4A—Axon guidance—IL6R—osteoporosis	0.000284	0.0022	CbGpPWpGaD
Tocainide—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—osteoporosis	0.000276	0.00214	CbGpPWpGaD
Tocainide—SCN1A—Axon guidance—IL6R—osteoporosis	0.000274	0.00212	CbGpPWpGaD
Tocainide—SCN10A—Axon guidance—IL6R—osteoporosis	0.000274	0.00212	CbGpPWpGaD
Tocainide—CYP1A2—Biological oxidations—CYP27A1—osteoporosis	0.000274	0.00212	CbGpPWpGaD
Tocainide—SCN8A—Developmental Biology—IL6R—osteoporosis	0.000273	0.00212	CbGpPWpGaD
Tocainide—CYP1A2—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	0.000271	0.0021	CbGpPWpGaD
Tocainide—CYP1A2—Metapathway biotransformation—CYP27A1—osteoporosis	0.00027	0.00209	CbGpPWpGaD
Tocainide—ALB—Selenium Micronutrient Network—MTHFR—osteoporosis	0.000264	0.00205	CbGpPWpGaD
Tocainide—SCN9A—Developmental Biology—LEP—osteoporosis	0.000263	0.00204	CbGpPWpGaD
Tocainide—SCN5A—SIDS Susceptibility Pathways—IL1B—osteoporosis	0.000263	0.00204	CbGpPWpGaD
Tocainide—ALB—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	0.000262	0.00203	CbGpPWpGaD
Tocainide—ALB—Platelet activation, signaling and aggregation—RAP1A—osteoporosis	0.00026	0.00202	CbGpPWpGaD
Tocainide—ALB—Hemostasis—CAP1—osteoporosis	0.00026	0.00202	CbGpPWpGaD
Tocainide—SCN3A—Developmental Biology—LEP—osteoporosis	0.000252	0.00195	CbGpPWpGaD
Tocainide—ALB—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	0.000248	0.00192	CbGpPWpGaD
Tocainide—ALB—Vitamin B12 Metabolism—IL1B—osteoporosis	0.000243	0.00188	CbGpPWpGaD
Tocainide—SCN2A—Developmental Biology—LEP—osteoporosis	0.000242	0.00188	CbGpPWpGaD
Tocainide—SCN4A—Developmental Biology—LEP—osteoporosis	0.000242	0.00188	CbGpPWpGaD
Tocainide—ALB—Platelet activation, signaling and aggregation—FGA—osteoporosis	0.000236	0.00183	CbGpPWpGaD
Tocainide—SCN1A—Developmental Biology—LEP—osteoporosis	0.000233	0.00181	CbGpPWpGaD
Tocainide—SCN10A—Developmental Biology—LEP—osteoporosis	0.000233	0.00181	CbGpPWpGaD
Tocainide—SCN9A—Developmental Biology—IL6R—osteoporosis	0.000221	0.00171	CbGpPWpGaD
Tocainide—ALB—Platelet degranulation—IGF1—osteoporosis	0.000219	0.0017	CbGpPWpGaD
Tocainide—ALB—Platelet activation, signaling and aggregation—FGB—osteoporosis	0.000215	0.00167	CbGpPWpGaD
Tocainide—SCN3A—Developmental Biology—IL6R—osteoporosis	0.000211	0.00164	CbGpPWpGaD
Tocainide—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—osteoporosis	0.000209	0.00162	CbGpPWpGaD
Tocainide—SCN7A—Axon guidance—IL6—osteoporosis	0.000209	0.00162	CbGpPWpGaD
Tocainide—ALB—Hemostasis—MGLL—osteoporosis	0.000207	0.0016	CbGpPWpGaD
Tocainide—SCN2A—Developmental Biology—IL6R—osteoporosis	0.000203	0.00157	CbGpPWpGaD
Tocainide—SCN4A—Developmental Biology—IL6R—osteoporosis	0.000203	0.00157	CbGpPWpGaD
Tocainide—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	0.000201	0.00156	CbGpPWpGaD
Tocainide—SCN7A—Developmental Biology—TGFB1—osteoporosis	0.000198	0.00153	CbGpPWpGaD
Tocainide—ALB—Folate Metabolism—IL1B—osteoporosis	0.000197	0.00153	CbGpPWpGaD
Tocainide—SCN1A—Developmental Biology—IL6R—osteoporosis	0.000195	0.00152	CbGpPWpGaD
Tocainide—SCN10A—Developmental Biology—IL6R—osteoporosis	0.000195	0.00152	CbGpPWpGaD
Tocainide—ALB—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	0.000193	0.0015	CbGpPWpGaD
Tocainide—SCN5A—Axon guidance—IL6R—osteoporosis	0.000193	0.00149	CbGpPWpGaD
Tocainide—SCN5A—SIDS Susceptibility Pathways—TNF—osteoporosis	0.000191	0.00148	CbGpPWpGaD
Tocainide—ALB—Hemostasis—ANXA2—osteoporosis	0.000189	0.00146	CbGpPWpGaD
Tocainide—ALB—Hemostasis—PLEK—osteoporosis	0.000189	0.00146	CbGpPWpGaD
Tocainide—ALB—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	0.000188	0.00146	CbGpPWpGaD
Tocainide—SCN11A—Axon guidance—IL6—osteoporosis	0.000186	0.00144	CbGpPWpGaD
Tocainide—SCN7A—Developmental Biology—TNF—osteoporosis	0.000185	0.00143	CbGpPWpGaD
Tocainide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—osteoporosis	0.000184	0.00143	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	0.000183	0.00142	CbGpPWpGaD
Tocainide—SCN11A—Developmental Biology—TGFB1—osteoporosis	0.000176	0.00137	CbGpPWpGaD
Tocainide—ALB—Vitamin B12 Metabolism—TNF—osteoporosis	0.000176	0.00136	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	0.000174	0.00135	CbGpPWpGaD
Tocainide—SCN8A—Axon guidance—IL6—osteoporosis	0.00017	0.00132	CbGpPWpGaD
Tocainide—SCN11A—Developmental Biology—TNF—osteoporosis	0.000165	0.00128	CbGpPWpGaD
Tocainide—SCN5A—Developmental Biology—LEP—osteoporosis	0.000164	0.00127	CbGpPWpGaD
Tocainide—ALB—Transmembrane transport of small molecules—ANXA2—osteoporosis	0.000164	0.00127	CbGpPWpGaD
Tocainide—ALB—Hemostasis—TLN1—osteoporosis	0.000163	0.00126	CbGpPWpGaD
Tocainide—CYP1A2—Phase 1 - Functionalization of compounds—POMC—osteoporosis	0.000163	0.00126	CbGpPWpGaD
Tocainide—SCN8A—Developmental Biology—TGFB1—osteoporosis	0.000161	0.00125	CbGpPWpGaD
Tocainide—ALB—Hemostasis—VCL—osteoporosis	0.000161	0.00125	CbGpPWpGaD
Tocainide—ALB—Selenium Micronutrient Network—IL1B—osteoporosis	0.000157	0.00122	CbGpPWpGaD
Tocainide—SCN5A—SIDS Susceptibility Pathways—IL6—osteoporosis	0.000154	0.00119	CbGpPWpGaD
Tocainide—SCN8A—Developmental Biology—TNF—osteoporosis	0.000151	0.00117	CbGpPWpGaD
Tocainide—ALB—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	0.00015	0.00117	CbGpPWpGaD
Tocainide—SCN7A—Developmental Biology—IL6—osteoporosis	0.000149	0.00116	CbGpPWpGaD
Tocainide—CYP1A2—Biological oxidations—CYP19A1—osteoporosis	0.000144	0.00112	CbGpPWpGaD
Tocainide—CYP1A2—Aryl Hydrocarbon Receptor—MYC—osteoporosis	0.000144	0.00111	CbGpPWpGaD
Tocainide—ALB—Folate Metabolism—TNF—osteoporosis	0.000143	0.00111	CbGpPWpGaD
Tocainide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—osteoporosis	0.000143	0.00111	CbGpPWpGaD
Tocainide—ALB—Vitamin B12 Metabolism—IL6—osteoporosis	0.000142	0.0011	CbGpPWpGaD
Tocainide—CYP1A2—Metapathway biotransformation—CYP19A1—osteoporosis	0.000142	0.0011	CbGpPWpGaD
Tocainide—SCN9A—Axon guidance—IL6—osteoporosis	0.000138	0.00107	CbGpPWpGaD
Tocainide—SCN5A—Developmental Biology—IL6R—osteoporosis	0.000137	0.00107	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	0.000135	0.00105	CbGpPWpGaD
Tocainide—ALB—Hemostasis—RAP1A—osteoporosis	0.000134	0.00104	CbGpPWpGaD
Tocainide—CYP1A2—Aryl Hydrocarbon Receptor—TNF—osteoporosis	0.000134	0.00104	CbGpPWpGaD
Tocainide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—osteoporosis	0.000134	0.00104	CbGpPWpGaD
Tocainide—SCN11A—Developmental Biology—IL6—osteoporosis	0.000133	0.00103	CbGpPWpGaD
Tocainide—SCN3A—Axon guidance—IL6—osteoporosis	0.000132	0.00102	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	0.000132	0.00102	CbGpPWpGaD
Tocainide—ALB—Platelet degranulation—TGFB1—osteoporosis	0.000131	0.00102	CbGpPWpGaD
Tocainide—SCN9A—Developmental Biology—TGFB1—osteoporosis	0.00013	0.00101	CbGpPWpGaD
Tocainide—ALB—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	0.000128	0.000991	CbGpPWpGaD
Tocainide—SCN4A—Axon guidance—IL6—osteoporosis	0.000127	0.000981	CbGpPWpGaD
Tocainide—SCN2A—Axon guidance—IL6—osteoporosis	0.000127	0.000981	CbGpPWpGaD
Tocainide—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—osteoporosis	0.000125	0.000971	CbGpPWpGaD
Tocainide—SCN3A—Developmental Biology—TGFB1—osteoporosis	0.000125	0.000967	CbGpPWpGaD
Tocainide—SCN10A—Axon guidance—IL6—osteoporosis	0.000122	0.000946	CbGpPWpGaD
Tocainide—SCN1A—Axon guidance—IL6—osteoporosis	0.000122	0.000946	CbGpPWpGaD
Tocainide—SCN9A—Developmental Biology—TNF—osteoporosis	0.000122	0.000944	CbGpPWpGaD
Tocainide—ALB—Hemostasis—FGA—osteoporosis	0.000122	0.000944	CbGpPWpGaD
Tocainide—SCN8A—Developmental Biology—IL6—osteoporosis	0.000122	0.000942	CbGpPWpGaD
Tocainide—SCN4A—Developmental Biology—TGFB1—osteoporosis	0.00012	0.000929	CbGpPWpGaD
Tocainide—SCN2A—Developmental Biology—TGFB1—osteoporosis	0.00012	0.000929	CbGpPWpGaD
Tocainide—ALB—Metabolism—FDPS—osteoporosis	0.000117	0.000904	CbGpPWpGaD
Tocainide—ALB—Metabolism—PKM—osteoporosis	0.000117	0.000904	CbGpPWpGaD
Tocainide—SCN3A—Developmental Biology—TNF—osteoporosis	0.000116	0.000903	CbGpPWpGaD
Tocainide—SCN10A—Developmental Biology—TGFB1—osteoporosis	0.000116	0.000896	CbGpPWpGaD
Tocainide—SCN1A—Developmental Biology—TGFB1—osteoporosis	0.000116	0.000896	CbGpPWpGaD
Tocainide—ALB—Folate Metabolism—IL6—osteoporosis	0.000116	0.000896	CbGpPWpGaD
Tocainide—ALB—Selenium Micronutrient Network—TNF—osteoporosis	0.000114	0.000882	CbGpPWpGaD
Tocainide—SCN2A—Developmental Biology—TNF—osteoporosis	0.000112	0.000868	CbGpPWpGaD
Tocainide—SCN4A—Developmental Biology—TNF—osteoporosis	0.000112	0.000868	CbGpPWpGaD
Tocainide—ALB—Hemostasis—FGB—osteoporosis	0.000111	0.000859	CbGpPWpGaD
Tocainide—ALB—Metabolism—GPD2—osteoporosis	0.000111	0.000857	CbGpPWpGaD
Tocainide—ALB—Metabolism—PGLS—osteoporosis	0.000111	0.000857	CbGpPWpGaD
Tocainide—SCN1A—Developmental Biology—TNF—osteoporosis	0.000108	0.000837	CbGpPWpGaD
Tocainide—SCN10A—Developmental Biology—TNF—osteoporosis	0.000108	0.000837	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	0.000105	0.000815	CbGpPWpGaD
Tocainide—ALB—Metabolism—ATIC—osteoporosis	0.000101	0.000784	CbGpPWpGaD
Tocainide—ALB—Metabolism—PNP—osteoporosis	0.000101	0.000784	CbGpPWpGaD
Tocainide—SCN9A—Developmental Biology—IL6—osteoporosis	9.83e-05	0.000762	CbGpPWpGaD
Tocainide—ALB—Platelet activation, signaling and aggregation—IGF1—osteoporosis	9.73e-05	0.000754	CbGpPWpGaD
Tocainide—SCN3A—Developmental Biology—IL6—osteoporosis	9.4e-05	0.000729	CbGpPWpGaD
Tocainide—ALB—Selenium Micronutrient Network—IL6—osteoporosis	9.18e-05	0.000712	CbGpPWpGaD
Tocainide—SCN4A—Developmental Biology—IL6—osteoporosis	9.03e-05	0.0007	CbGpPWpGaD
Tocainide—SCN2A—Developmental Biology—IL6—osteoporosis	9.03e-05	0.0007	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	8.94e-05	0.000693	CbGpPWpGaD
Tocainide—SCN10A—Developmental Biology—IL6—osteoporosis	8.71e-05	0.000675	CbGpPWpGaD
Tocainide—SCN1A—Developmental Biology—IL6—osteoporosis	8.71e-05	0.000675	CbGpPWpGaD
Tocainide—CYP1A2—Biological oxidations—POMC—osteoporosis	8.64e-05	0.00067	CbGpPWpGaD
Tocainide—ALB—Metabolism—CA2—osteoporosis	8.59e-05	0.000666	CbGpPWpGaD
Tocainide—ALB—Metabolism—OXCT1—osteoporosis	8.59e-05	0.000666	CbGpPWpGaD
Tocainide—SCN5A—Axon guidance—IL6—osteoporosis	8.58e-05	0.000665	CbGpPWpGaD
Tocainide—ALB—Metabolism—MGLL—osteoporosis	8.37e-05	0.000649	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—PKM—osteoporosis	8.15e-05	0.000632	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—FDPS—osteoporosis	8.15e-05	0.000632	CbGpPWpGaD
Tocainide—SCN5A—Developmental Biology—TGFB1—osteoporosis	8.12e-05	0.00063	CbGpPWpGaD
Tocainide—ALB—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	7.9e-05	0.000612	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—PGLS—osteoporosis	7.73e-05	0.000599	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—GPD2—osteoporosis	7.73e-05	0.000599	CbGpPWpGaD
Tocainide—SCN5A—Developmental Biology—TNF—osteoporosis	7.59e-05	0.000588	CbGpPWpGaD
Tocainide—ALB—Metabolism—IDH2—osteoporosis	7.12e-05	0.000552	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—PNP—osteoporosis	7.07e-05	0.000548	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—ATIC—osteoporosis	7.07e-05	0.000548	CbGpPWpGaD
Tocainide—ALB—Metabolism—CYP27A1—osteoporosis	6.69e-05	0.000519	CbGpPWpGaD
Tocainide—ALB—Metabolism—ACP5—osteoporosis	6.51e-05	0.000505	CbGpPWpGaD
Tocainide—ALB—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	6.43e-05	0.000499	CbGpPWpGaD
Tocainide—ALB—Transmembrane transport of small molecules—ADCY5—osteoporosis	6.14e-05	0.000476	CbGpPWpGaD
Tocainide—SCN5A—Developmental Biology—IL6—osteoporosis	6.12e-05	0.000475	CbGpPWpGaD
Tocainide—ALB—Metabolism—TPI1—osteoporosis	6.05e-05	0.00047	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—OXCT1—osteoporosis	6.01e-05	0.000466	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—CA2—osteoporosis	6.01e-05	0.000466	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—MGLL—osteoporosis	5.86e-05	0.000454	CbGpPWpGaD
Tocainide—ALB—Platelet activation, signaling and aggregation—TGFB1—osteoporosis	5.83e-05	0.000452	CbGpPWpGaD
Tocainide—ALB—Metabolism—P4HB—osteoporosis	5.69e-05	0.000441	CbGpPWpGaD
Tocainide—ALB—Metabolism—GAPDH—osteoporosis	5.59e-05	0.000433	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	5.52e-05	0.000428	CbGpPWpGaD
Tocainide—ALB—Metabolism—RAP1A—osteoporosis	5.44e-05	0.000422	CbGpPWpGaD
Tocainide—ALB—Hemostasis—IGF1—osteoporosis	5.01e-05	0.000389	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—IDH2—osteoporosis	4.98e-05	0.000386	CbGpPWpGaD
Tocainide—ALB—Metabolism of lipids and lipoproteins—POMC—osteoporosis	4.75e-05	0.000368	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—CYP27A1—osteoporosis	4.68e-05	0.000363	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—ACP5—osteoporosis	4.56e-05	0.000353	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	4.5e-05	0.000349	CbGpPWpGaD
Tocainide—ALB—Metabolism—ENO1—osteoporosis	4.4e-05	0.000341	CbGpPWpGaD
Tocainide—ALB—Metabolism—PSMA5—osteoporosis	4.33e-05	0.000336	CbGpPWpGaD
Tocainide—ALB—Metabolism—PSMA2—osteoporosis	4.33e-05	0.000336	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—TPI1—osteoporosis	4.24e-05	0.000328	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—P4HB—osteoporosis	3.98e-05	0.000309	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—GAPDH—osteoporosis	3.91e-05	0.000303	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—RAP1A—osteoporosis	3.81e-05	0.000295	CbGpPWpGaD
Tocainide—ALB—Metabolism—CYP19A1—osteoporosis	3.52e-05	0.000273	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	3.32e-05	0.000257	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—ENO1—osteoporosis	3.08e-05	0.000239	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—PSMA2—osteoporosis	3.03e-05	0.000235	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—PSMA5—osteoporosis	3.03e-05	0.000235	CbGpPWpGaD
Tocainide—ALB—Hemostasis—TGFB1—osteoporosis	3.01e-05	0.000233	CbGpPWpGaD
Tocainide—ALB—Metabolism—ADCY5—osteoporosis	2.87e-05	0.000223	CbGpPWpGaD
Tocainide—ALB—Metabolism—GPX1—osteoporosis	2.86e-05	0.000222	CbGpPWpGaD
Tocainide—ALB—Metabolism—MTHFR—osteoporosis	2.64e-05	0.000205	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—CYP19A1—osteoporosis	2.46e-05	0.000191	CbGpPWpGaD
Tocainide—ALB—Metabolism—POMC—osteoporosis	2.11e-05	0.000164	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—ADCY5—osteoporosis	2.01e-05	0.000156	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—GPX1—osteoporosis	2e-05	0.000155	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—MTHFR—osteoporosis	1.85e-05	0.000143	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—POMC—osteoporosis	1.48e-05	0.000115	CbGpPWpGaD
